Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker? - Wikidata - awgldk - TriplyDB

Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?

Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?

http://www.wikidata.org/entity/Q36245922

about

Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis Puerarin Protects against Cardiac Fibrosis Associated with the Inhibition of TGF-β1/Smad2-Mediated Endothelial-to-Mesenchymal Transition.Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target.A candidate gene study reveals association between a variant of the Peroxisome Proliferator-Activated Receptor Gamma (PPAR-γ) gene and systemic sclerosis The Histone Deacetylase Sirtuin 1 Is Reduced in Systemic Sclerosis and Abrogates Fibrotic Responses by Targeting Transforming Growth Factor β Signaling.Regulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis.The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy.Effectiveness of rosiglitazone in reducing flexion contracture in a rabbit model of arthrofibrosis with surgical capsular release: A biomechanical, histological, and genetic analysis Peroxisome proliferator-activated receptor-γ agonist troglitazone suppresses transforming growth factor-β1 signalling through miR-92b upregulation-inhibited Axl expression in human keloid fibroblasts in vitro.Dendritic cells maintain dermal adipose-derived stromal cells in skin fibrosis.What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis?Current status of systemic sclerosis biomarkers: applications for diagnosis, management and drug development.Novel investigational agents for the treatment of scleroderma.The Role of PPAR Gamma in Systemic Sclerosis.Elevated Adipsin Levels are Associated with Pulmonary Arterial Hypertension in Systemic Sclerosis.Biomarkers in Scleroderma: Progressing from Association to Clinical Utility.Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in 104 patients with systemic sclerosis.An update on biomarker discovery and use in systemic sclerosis.Serum adipokines levels in patients with systemic sclerosis: A meta-analysis.Adiponectin Is Involved in Connective Tissue Growth Factor-Induced Proliferation, Migration and Overproduction of the Extracellular Matrix in Keloid Fibroblasts.Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease.Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma.Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis.Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up-regulating matrix metalloproteinase 9 expression in mice.Association between Functional CYP2D6 Polymorphisms and Susceptibility to Autoimmune Diseases: A Meta-Analysis.Serum adropin level and ENHO gene expression in systemic sclerosis.Serum omentin levels: A possible contribution to vascular involvement in patients with systemic sclerosis.Meta-analysis of circulating adiponectin, leptin, and resistin levels in systemic sclerosis.Bleomycin inhibits adipogenesis and accelerates fibrosis in the subcutaneous adipose layer through TGF-β1.Novel classification for global gene signature model for predicting severity of systemic sclerosis.An orally-active adiponectin receptor agonist mitigates cutaneous fibrosis, inflammation and microvascular pathology in a murine model of systemic sclerosis

P2860

Q33736823-C29EBA51-363D-45A1-AA88-C6B4F8A050B0 Q33790719-F04B1C13-FF65-420A-888A-79F74C7508E7 Q33860888-283F18AF-E830-414C-9E6F-9E3A8902E326 Q35623780-1557DD61-9BE8-4C63-992B-09A2E9750300 Q35899944-C0B8C6B2-9345-4982-8F3E-677F4F1E2AD9 Q36093802-C3B9E47E-EF8C-4794-98D0-D82ECEC1B686 Q36633255-386B4569-7984-4EF3-84D4-882D7D44228A Q37227633-3FEB9BF7-0DE2-4C11-A1BF-B1D9B83FF4D0 Q37227987-DE73DE8F-878D-4C62-8FEA-E09A02A11840 Q37395851-08B50633-4A2F-400F-8CB2-79954A571E5C Q38141638-D1221264-3859-43B1-95A9-2FEC95E07970 Q38156227-0F8CD6EE-1B72-4DB7-A9DB-3BF04DD8D222 Q38164818-D3819BB4-E471-4DFE-9CF0-77C822177E70 Q38524619-0C83C3E5-9756-40D7-B5C4-1879B2E1868D Q38708686-9C810406-3AB4-409B-87FF-C9FEFEFA9123 Q38771824-029B7218-A493-4B79-BCF0-6DC37B1F28B7 Q38922023-BDE78A2A-5FBE-4227-B0FF-1FF800DD2574 Q39450087-6DE71902-48F7-466B-A2C4-5E7964D17E5F Q39671627-982A943D-953F-43F8-948F-E289C2FF70CF Q42229072-6BC95A63-31B2-4E74-9D6B-5A6D9A369563 Q45975840-1C8441DE-045E-4635-A43A-379EA1060205 Q47095125-7872FCB5-0D8A-47F0-ABE0-26822C69B7D7 Q47109594-F97163EC-7BFF-4290-8AC2-00F1C03FD2A3 Q47110057-8E29B74F-04A1-4306-AC3A-417C258323C6 Q51385249-12D95084-7811-4618-BD18-74D7DCEDCB02 Q53122357-A44E379C-9F63-4DD1-B9E0-1893FB48354B Q53580852-4EEDB30B-712B-40E1-8A84-5139284F01AE Q54162257-A91EF9EB-F730-4143-8B4E-5C3AA27486D1 Q54776294-246E04F7-A9A3-4D01-8C1A-E861478794CD Q55490826-D980539B-D863-4F90-8AAF-E382B77EDD80 Q58797878-BF450504-29DE-46D9-BE7C-4BEE34890CEB

P2860

Levels of adiponectin, a marker for PPAR-gamma activity, correlate with skin fibrosis in systemic sclerosis: potential utility as biomarker?

http://www.wikidata.org/entity/Q36245922

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Levels of adiponectin, a marke ...... otential utility as biomarker?

@ast

Levels of adiponectin, a marke ...... otential utility as biomarker?

@en

type

label

Levels of adiponectin, a marke ...... otential utility as biomarker?

@ast

Levels of adiponectin, a marke ...... otential utility as biomarker?

@en

prefLabel

Levels of adiponectin, a marke ...... otential utility as biomarker?

@ast

Levels of adiponectin, a marke ...... otential utility as biomarker?

@en

P1433

Q36245922-AF4EAA8F-B353-4968-ACC1-BFF5A5D30406

P1476

Q36245922-64F6CC37-AB5F-4533-AAEC-33E298FF7D9C

P2093

Q36245922-4D8A01E6-03B0-4B1F-A27A-5859A0D75532

Q36245922-8AFC5592-F731-4E2F-AED8-A75D4E8D5A00

Q36245922-A812F5E0-2854-4BF1-A229-45F3CB37F685

Q36245922-D4200D3E-1826-4BEE-86AF-D981F7897D43

Q36245922-E270AD1C-66B7-4D3B-B8FD-E28ACFB4A0EF

Q36245922-EAFD31F1-0792-44B2-A203-D724DB1F4AED

Q36245922-EF5D61C4-F5FE-427C-81A9-D8D77E2922A3

P2860

Q36245922-08A5068B-BE37-43C9-B78B-4FBAB4D76859

Q36245922-0941F450-CD22-457C-A3C6-3824911E370A

Q36245922-29071C32-BD0D-4F64-B839-23E9E3AE7512

Q36245922-2EB6507E-35A9-449D-B534-8A5A20DD4F36

Q36245922-3A43D06A-F313-4D2B-A8E2-A9AFC2C5BDF7

Q36245922-3BC5023C-B838-4FF9-A0AD-DB78243141F8

Q36245922-43A611C2-6255-4D98-BA92-B27D51E7E351

Q36245922-47EEA5EB-6660-4DED-A45C-13181111E6DA

Q36245922-48D83DD7-72BF-493F-B2A1-4A57EEC7B5E7

Q36245922-4C98F877-9BE4-4C2C-9C68-68660AD2CCD3

P2888

Q36245922-DB5D03DC-4D08-490B-A601-40650720FF05

P304

Q36245922-2E0D3033-021B-489E-9B03-3E5E8D290772

P31

Q36245922-DD9327CD-226C-4ED4-8C22-AE6DEE7BDFCF

P356

Q36245922-BB88BA0F-1518-45BA-9AF4-C57B87CDD7DD

P433

Q36245922-70305044-D196-4FD4-BD5D-F990B0A2CE5B

P478

Q36245922-3A99334D-36A7-4C55-B9EF-B33749F5464E

P50

Q36245922-7B8CCB59-551F-4090-BBF6-1E334A395C47

P577

Q36245922-08BD0D16-B1E6-413D-8A9E-C4B5A5E17108

P5875

Q36245922-C5E3639E-6548-47B7-90EE-629468349EF5

P6179

Q36245922-52CB0B03-63F6-4402-8C7D-B8778CBC9B77

P698

Q36245922-82F160A9-8A75-4293-A32D-7F1B141FED65

P921

Q36245922-125998BB-2A92-4595-A133-3E4B4D5A2235

P932

Q36245922-2AD7FE26-507B-40B3-B98D-AFF1A68B604A

P356

P1433

Arthritis Research and Therapy

P1476

Levels of adiponectin, a marke ...... otential utility as biomarker?

@en

P2093

John Varga

http://www.w3.org/2001/XMLSchema#string

Jun Wei

http://www.w3.org/2001/XMLSchema#string

Jungwha Lee

http://www.w3.org/2001/XMLSchema#string

Mary Carns

http://www.w3.org/2001/XMLSchema#string

Michael L Whitfield

http://www.w3.org/2001/XMLSchema#string

Monique Hinchcliff

http://www.w3.org/2001/XMLSchema#string

Snezna Sodin-Semrl

http://www.w3.org/2001/XMLSchema#string

P2860

Adiponectin activation of AMPK disrupts leptin-mediated hepatic fibrosis via suppressors of cytokine signaling (SOCS-3)

Fat and beyond: the diverse biology of PPARgamma

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.

Molecular subsets in the gene expression signatures of scleroderma skin.

PPARγ downregulation by TGFß in fibroblast and impaired expression and function in systemic sclerosis: a novel mechanism for progressive fibrogenesis

PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis.

Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis.

Criteria for the classification of early systemic sclerosis.

Elevated adiponectin serum levels in women with systemic autoimmune diseases

Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosis

P2888

P304

R102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/AR3827

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224878003

http://www.w3.org/2001/XMLSchema#string

P6179

1020136644

http://www.w3.org/2001/XMLSchema#string

P698

22548780

http://www.w3.org/2001/XMLSchema#string

P921

P932

3446479

http://www.w3.org/2001/XMLSchema#string